The Journal of Pediatrics
Volume 152, Issue 1 , Pages 3-4 , January 2008

How Far Can Prenatal Screening Go in Preventing Birth Defects?

  • David A. Savitz, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: David A. Savitz, PhD, Department of Community & Preventive Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1057, New York, NY 10029-6574.

References 

  1. Collins VR, Muggli EE, Riley M, Palma S, Halliday JL. Is Down syndrome a disappearing birth defect?. J Pediatr. 2008;152:20–24
  2. Scotet V, Assael BM, Duguépéroux I, Tamanini A, Audrézet M-P, Férec C, et al. Time trends in birth incidence of cystic fibrosis in two European regions: data from newborn screening programs. J Pediatr. 2008;152:25–33
  3. Reddy UM, Mennuti MT. Incorporating first-trimester Down syndrome studies into prenatal screening (Executive summary of the National Institute of Child Health and Human Development Workshop). Obstet Gynecol. 2006;107:167–173
  4. Wald NJ, Morris JK, Rodeck CH, Haddow JE, Palomaki GE. Cystic fibrosis: selecting the prenatal screening strategy of choice. Prenat Diagn. 2003;23:474–483
  5. Reynolds TM. Screening by test combination: a statistical overview. In:  Grudzinskas JG,  Chard T,  Chapman M,  Cuckle H editor. Screening for Down’s syndrome. Cambridge: Cambridge University Press; 1994;p. 47–72

PII: S0022-3476(07)00857-8

doi: 10.1016/j.jpeds.2007.09.012

The Journal of Pediatrics
Volume 152, Issue 1 , Pages 3-4 , January 2008

Article Tools